Insider trade

Director reported a gift or transfer of 892K CORT shares

Traded May 27, 2026 · Filed May 30, 2026

Corcept TherapeuticsCORT

892K
Shares

Why it stands out

Gift or transfer — classified separately from trades.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: May 27, 2026
Reporting period: Not applicable
Filed with the SEC: May 30, 2026

DirectorIndirect holdingGift / transfer

Context

Classification

gift transfer

Code G — gift, bequest or transfer

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Source receipt

Record ID

0001193125-26-248953

Filed / recorded

May 30, 2026, 1:56 AM UTC

Added to OQRO

Oct 6, 2026, 7:14 PM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

CORCEPT THERAPEUTICS INC

Issuer CIK

1088856

Ticker

CORT

Reporting person

James N Wilson

Relationship

Director

Security

Common Stock

Table

Non-derivative (Table I)

Transaction date

May 27, 2026

Transaction code

G

Shares / units

892,056

Price per share

$0.00

Acquired / disposed

Disposed (D)

Shares owned after

9,011

Ownership form

Indirect — James and Pamela Wilson Family Partners

Amendment

No

Footnotes from the filing

Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust and James and Pamela Wilson Family Partners pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein.

Around the same time

James N Wilson (Director) sold ~$345K of Corcept Therapeutics

Scheduled in advanceFiled 4mo ago

James N Wilson (Director) sold ~$487K of Corcept Therapeutics

Scheduled in advanceFiled 4mo ago

David L MahoneyDirector

Filed 4mo ago

Sold

~$1.69M20K sh @ $84.53

Traded Jun 17 · filed 2 days laterNot under a reported trading plan

A Corcept Therapeutics director sold $1.69M of Corcept Therapeutics shares. The filing does not indicate a pre-arranged trading plan.

More Official record